All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong BuyZacks Investment Research • 08/21/25
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic GrowthGlobeNewsWire • 08/19/25
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/07/25
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceGlobeNewsWire • 08/07/25
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?Zacks Investment Research • 07/25/25
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ETGlobeNewsWire • 07/17/25
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?Zacks Investment Research • 07/16/25
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?Zacks Investment Research • 07/11/25
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?Zacks Investment Research • 07/04/25
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to BuyZacks Investment Research • 06/06/25
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 GuidanceGlobeNewsWire • 05/12/25